Healthcare Services

Transcriptomics Market Projected To Surpass $10.29 Billion By 2030 At 7.8% CAGR

June 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Transcriptomics Market?

The transcriptomics market size has demonstrated strong expansion over recent years. Forecasts indicate its growth from $7.04 billion in 2025 to $7.61 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.1%. This historical growth can be linked to several contributing factors, including advancements in sequencing technologies, the decreasing cost of high-throughput analysis, the expansion of academic genomics research, the availability of standardized transcriptomic workflows, and an increase in life sciences funding.

The transcriptomics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $10.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. Factors driving this growth during the projected period include the growing incorporation of AI-powered data analysis, an escalating need for personalized therapeutic solutions, the broadening scope of clinical transcriptomics applications, increasing investments in omics research infrastructure, and the heightened adoption of transcriptomic profiling by pharmaceutical companies. Key trends anticipated within the forecast timeframe encompass the expanding utilization of RNA sequencing technologies, the increasing application of single-cell transcriptomics, the development of bioinformatics and data analytics platforms, a surging demand for biomarker discovery applications, and a greater emphasis on precision medicine.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

Which Core Factors Are Supporting The Expansion Of The Transcriptomics Market?

The future expansion of the transcriptomics market is anticipated to be driven by the rising acceptance of personalized medicine. This medical approach involves tailoring treatments specifically to an individual’s genetic makeup, lifestyle choices, and environmental factors. Its growth is fueled by advancements in genetic sequencing technology, allowing for treatments to be precisely matched to individual genetic profiles, thereby enhancing their efficacy. Transcriptomics plays a crucial role by revealing unique gene expression profiles for each person, which in turn informs personalized treatments aligned with a patient’s distinct biological characteristics. This contributes to improved therapeutic outcomes, reduced adverse reactions, and facilitates the early detection of diseases. A notable example is the report from February 2024 by the Personalized Medicine Coalition, a US hospital and healthcare organization, stating that the FDA cleared 16 new personalized therapies for individuals with rare diseases in 2023, an increase from six approvals in 2022. Consequently, the expanding implementation of personalized medicine is a key factor propelling the transcriptomics market forward.

Which Segment Groups Define The Transcriptomics Market Landscape?

The transcriptomics market covered in this report is segmented –

1) By Type: Instruments, Consumables, Software, Services

2) By Technology: Micro Array, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies

3) By Application: Diagnostics And Disease Profiling, Drug Discovery, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Microarray Instruments, Sequencing Instruments, Polymerase Chain Reaction (PCR) Instruments, Other Transcriptomics Instruments

2) By Consumables: Reagents, Probes, Kits, Chips

3) By Software: Data Analysis Software: Data Management Software, Visualization Software: Bioinformatics Software

4) By Services: Data Analysis Services, Sample Preparation Services, Sequencing Services, Consulting Services

What Trends Are Affecting The Growth Of The Transcriptomics Market?

Major companies operating in the tracheitis treatment market are concentrating on developing innovative products, such as novel antibiotics, to combat resistant infections and enhance patient outcomes. A novel antibiotic refers to a recently developed or discovered antibiotic that targets bacteria in a distinctive manner, often proving effective against drug-resistant strains or infections not treated by existing antibiotics. For instance, in September 2024, Wockhardt Ltd., an India-based pharmaceutical company, introduced a novel antibiotic drug, WCK 5222, branded as Zaynich. This medication will be priced in India at 80% less than its US counterpart, thereby increasing its accessibility for local patients battling infections caused by multi-drug-resistant (MDR) bacteria. This strategic pricing initiative aims to improve treatment adherence and address the pressing demand for potent antibiotics within the region.

Who Are The Companies Shaping The Transcriptomics Market Landscape?

Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Access The Complete Transcriptomics Market Report:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Which Region Has The Strongest Presence In The Transcriptomics Market?

North America was the largest region in the transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Transcriptomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

Browse Through More Reports Similar to the Global Transcriptomics Market 2026, By The Business Research Company

Genomics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Rna Sequencing Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795